IYR vs XLV
iShares US Real Estate ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.37% for IYR.
- • IYR pays a higher dividend yield (2.39%).
Side-by-side metrics
| Metric | IYR | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.37% | 0.08% |
Dividend yield Trailing 12-month yield. | 2.39% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $4.03B | $49.10B |
YTD return | 11.57% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.92 | 0.41 |
P/E ratio | 26.29 | 30.63 |
Last price | $102.52 | $187.94 |
Inception | — | — |
Issuer | iShares | State Street |
IYR top holdings
| WELL | Welltower Inc | 10.05% |
| PLD | Prologis Inc | 8.75% |
| AMT | American Tower Corp | 4.99% |
| SPG | Simon Property Group Inc | 4.76% |
| EQIX | Equinix Inc | 4.57% |
| DLR | Digital Realty Trust Inc | 4.52% |
| PSA | Public Storage | 4.20% |
| O | Realty Income Corp | 4.14% |
| VMRK | Vivmark Residential | 3.43% |
| VTR | Ventas Inc | 3.34% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About IYR
IYR (iShares US Real Estate ETF) is US real estate companies and REITs. Managed by iShares, the fund carries $4.0B in assets under management, an expense ratio of 0.37%, a dividend yield of 2.39%. Its largest holding is Welltower Inc (WELL), which represents 10.0% of the portfolio. Real Estate is the fund's largest sector exposure at 99.5%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.